# MedLeanRx reviews (2026): GLP-1 telehealth sellers | This GLP The pricing is reasonable and the catalog is sensible. Forty-nine states cannot reach either. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/medleanrx Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Almost nobody can buy it # MedLeanRx review The pricing is reasonable and the catalog is sensible. Forty-nine states cannot reach either. ## The verdict MedLeanRx prices semaglutide at $149 a month as a vial or a tablet and tirzepatide at $269. Its recorded coverage is a single state, and the tirzepatide discount narrows further to Texas. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection · Oral States 1 Injection From $149/mo Oral From $149/mo Prescription Required Compounded Yes — not FDA-approved Availability 1 state MedLeanRx offers semaglutide two ways at one price and tirzepatide by injection. A short-term tirzepatide bundle runs alongside, geographically restricted. 1. ## Who writes the prescription, and what do they see? A prescription comes before dispensing. Who writes it, and how often anything is reviewed afterwards, is not described. Charging the same for the needle and the tablet is genuinely good practice. It matters to whoever lives in the one state where it applies. 2. ## What happens when the dose goes up? The seller writes that plans start at $149 for the starting dose, and that pricing may vary with medication and dosage. That sentence concedes movement and declines to quantify it. 3. ## What the price includes Half a year of semaglutide comes to $894 by either route, and tirzepatide to $1,614. The Texas bundle is $325 for two months at 2 mg weekly, near $163 a month, and it lasts while stock does. 4. ## What it claims, and what it cites All lines are compounded to order by an unnamed pharmacy. Nothing is inspected by a regulator before it ships. ## Where it holds up, and where it does not - Strength: Needle and tablet share one price - Strength: The bundle states 2 mg weekly - Strength: Two semaglutide routes are offered - Limitation: Recorded coverage is a single state - Limitation: The bundle narrows to Texas and to stock - Limitation: The seller concedes the price may vary - Limitation: No pharmacy is identified ## What the evidence says about this kind of treatment The assessment above is about MedLeanRx. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A reader who happens to live where this seller operates. Wrong for Almost everyone else, on coverage alone. ## The evidence behind what MedLeanRx prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How MedLeanRx compares | Seller | Who it suits | Go | | --- | --- | --- | | Edessa | Readers who will read the plan table rather than the homepage banner | | | SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate | | | Recovery Delivered | Readers who reward a seller for publishing the number that costs it sales | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [Bioverse](https://thisglp.com/reviews/bioverse) [Blis MD](https://thisglp.com/reviews/blis-md) [Bliv](https://thisglp.com/reviews/bliv) [Bloom MD](https://thisglp.com/reviews/bloommd) [BloomWell Rx](https://thisglp.com/reviews/bloomwell-rx) [Blue Haven RX](https://thisglp.com/reviews/blue-haven-rx) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked Is the tablet dearer than the vial? No. Both semaglutide routes are $149. Who qualifies for the bundle? Texas clients, while stock lasts, at $325 for two months. How wide is coverage? One state. Is MedLeanRx legit? MedLeanRx is a GLP-1 telehealth sellers service. Its stated availability: 1 state. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay. Is MedLeanRx expensive compared with other GLP-1 telehealth sellers? MedLeanRx publishes a starting figure of $149/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts MedLeanRx below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).